Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 113

    1.

    Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.

    Duncan GE, Inada K, Koller BH, Moy SS.

    Brain Res. 2009 Oct 22. [Epub ahead of print]PMID: 19840778 [PubMed - as supplied by publisher]Related articles

    2.

    Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress.

    Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS.

    Brain Res. 2009 Apr 10;1265:186-95. Epub 2009 Feb 13.PMID: 19232330 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

    Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG.

    Pharmacol Rev. 2008 Sep;60(3):358-403. Review. Erratum in: Pharmacol Rev. 2008 Dec;60(4):582. PMID: 18922967 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.

    Duncan GE, Inada K, Farrington JS, Koller BH.

    Brain Res. 2008 Jul 24;1221:41-8. Epub 2008 May 8.PMID: 18550035 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Unique environmental effects on physical activity participation: a twin study.

    Duncan GE, Goldberg J, Noonan C, Moudon AV, Hurvitz P, Buchwald D.

    PLoS One. 2008 Apr 16;3(4):e2019.PMID: 18414678 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Worksite study promoting activity and changes in eating (PACE): design and baseline results.

    Beresford SA, Locke E, Bishop S, West B, McGregor BA, Bruemmer B, Duncan GE, Thompson B.

    Obesity (Silver Spring). 2007 Nov;15 Suppl 1:4S-15S.PMID: 18073337 [PubMed - indexed for MEDLINE]Related articles

    7.

    Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

    Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW.

    Behav Brain Res. 2008 Mar 17;188(1):178-94. Epub 2007 Nov 4.PMID: 18068825 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol.

    Inada K, Farrington JS, Moy SS, Koller BH, Duncan GE.

    J Neural Transm. 2007 Jul;114(7):899-908. Epub 2007 Feb 22.PMID: 17318306 [PubMed - in process]Related articles

    9.

    Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.

    Duncan GE, Moy SS, Lieberman JA, Koller BH.

    Pharmacol Biochem Behav. 2006 Nov;85(3):481-91. Epub 2006 Nov 13.PMID: 17097724 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?

    Marx CE, Shampine LJ, Duncan GE, VanDoren MJ, Grobin AC, Massing MW, Madison RD, Bradford DW, Butterfield MI, Lieberman JA, Morrow AL.

    Pharmacol Biochem Behav. 2006 Aug;84(4):598-608. Epub 2006 Sep 8.PMID: 16962649 [PubMed - indexed for MEDLINE]Related articles

    11.

    Population-based reference standards for cardiovascular fitness among U.S. adults: NHANES 1999-2000 and 2001-2002.

    Sanders LF, Duncan GE.

    Med Sci Sports Exerc. 2006 Apr;38(4):701-7.PMID: 16679986 [PubMed - indexed for MEDLINE]Related articles

    13.

    Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.

    Moy SS, Perez A, Koller BH, Duncan GE.

    Brain Res. 2006 May 17;1089(1):186-94. Epub 2006 Apr 25.PMID: 16638606 [PubMed - indexed for MEDLINE]Related articles

    14.

    Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome.

    Duncan GE.

    Curr Diab Rep. 2006 Feb;6(1):29-35. Review.PMID: 16522278 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.

    Duncan GE, Moy SS, Lieberman JA, Koller BH.

    Psychopharmacology (Berl). 2006 Jan;184(2):190-200. Epub 2005 Dec 16.PMID: 16362405 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prescribing exercise at varied levels of intensity and frequency: a randomized trial.

    Duncan GE, Anton SD, Sydeman SJ, Newton RL Jr, Corsica JA, Durning PE, Ketterson TU, Martin AD, Limacher MC, Perri MG.

    Arch Intern Med. 2005 Nov 14;165(20):2362-9.PMID: 16287765 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model.

    Duncan GE, Kohn H.

    Epilepsy Res. 2005 Oct-Nov;67(1-2):81-7. Epub 2005 Oct 6.PMID: 16214306 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cardiovascular fitness among U.S. adults: NHANES 1999-2000 and 2001-2002.

    Duncan GE, Li SM, Zhou XH.

    Med Sci Sports Exerc. 2005 Aug;37(8):1324-8.PMID: 16118579 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of exercise on emerging and traditional cardiovascular risk factors.

    Duncan GE, Perri MG, Anton SD, Limacher MC, Martin AD, Lowenthal DT, Arning E, Bottiglieri T, Stacpoole PW.

    Prev Med. 2004 Nov;39(5):894-902.PMID: 15475021 [PubMed - indexed for MEDLINE]Related articles

    21.

    Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction.

    Miyamoto S, Snouwaert JN, Koller BH, Moy SS, Lieberman JA, Duncan GE.

    Neuropsychopharmacology. 2004 Dec;29(12):2180-8.PMID: 15467708 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000.

    Duncan GE, Li SM, Zhou XH.

    Diabetes Care. 2004 Oct;27(10):2438-43.PMID: 15451913 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.

    Miyamoto S, Duncan GE, Marx CE, Lieberman JA.

    Mol Psychiatry. 2005 Jan;10(1):79-104. Review.PMID: 15289815 [PubMed - indexed for MEDLINE]Related articles

    24.

    Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

    Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH.

    Behav Brain Res. 2004 Aug 31;153(2):507-19.PMID: 15265649 [PubMed - indexed for MEDLINE]Related articles

    25.

    Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism.

    Duncan GE, Perkins LA, Theriaque DW, Neiberger RE, Stacpoole PW.

    J Clin Endocrinol Metab. 2004 Apr;89(4):1733-8.PMID: 15070938 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets.

    Fuehrlein BS, Rutenberg MS, Silver JN, Warren MW, Theriaque DW, Duncan GE, Stacpoole PW, Brantly ML.

    J Clin Endocrinol Metab. 2004 Apr;89(4):1641-5.PMID: 15070924 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Recent advances in the neurobiology of schizophrenia.

    Miyamoto S, LaMantia AS, Duncan GE, Sullivan P, Gilmore JH, Lieberman JA.

    Mol Interv. 2003 Feb;3(1):27-39. Review.PMID: 14993436 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Comparison of perceived health to physiological measures of health in Black and White women.

    Duncan GE, Anton SD, Newton RL Jr, Perri MG.

    Prev Med. 2003 May;36(5):624-8.PMID: 12689808 [PubMed - indexed for MEDLINE]Related articles

    29.

    Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation.

    Duncan GE, Miyamoto S, Lieberman JA.

    J Pharmacol Exp Ther. 2003 Jun;305(3):999-1005. Epub 2003 Mar 6.PMID: 12626664 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults.

    Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW.

    Diabetes Care. 2003 Mar;26(3):557-62.PMID: 12610001 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.

    Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL.

    Neuropsychopharmacology. 2003 Jan;28(1):1-13.PMID: 12496935 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    QUICKI is not a useful and accurate index of insulin sensitivity following exercise training.

    Duncan GE, Hutson AD, Stacpoole PW.

    J Clin Endocrinol Metab. 2002 Feb;87(2):950-1. No abstract available. PMID: 11836352 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration.

    Knapp DJ, Braun CJ, Duncan GE, Qian Y, Fernandes A, Crews FT, Breese GR.

    Alcohol Clin Exp Res. 2001 Nov;25(11):1662-72.PMID: 11707641 [PubMed - indexed for MEDLINE]Related articles

    34.

    QUICKI does not accurately reflect changes in insulin sensitivity with exercise training.

    Duncan GE, Hutson AD, Stacpoole PW.

    J Clin Endocrinol Metab. 2001 Sep;86(9):4115-9.PMID: 11549635 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Can sedentary adults accurately recall the intensity of their physical activity?

    Duncan GE, Sydeman SJ, Perri MG, Limacher MC, Martin AD.

    Prev Med. 2001 Jul;33(1):18-26.PMID: 11482992 [PubMed - indexed for MEDLINE]Related articles

    36.

    Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors.

    Miyamoto S, Mailman RB, Lieberman JA, Duncan GE.

    Brain Res. 2001 Mar 16;894(2):167-80.PMID: 11251190 [PubMed - indexed for MEDLINE]Related articles

    37.

    Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil.

    Moy SS, Knapp DJ, Duncan GE, Breese GR.

    Psychopharmacology (Berl). 2000 Oct;152(2):208-15.PMID: 11057525 [PubMed - indexed for MEDLINE]Related articles

    38.

    Olanzapine increases allopregnanolone in the rat cerebral cortex.

    Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL.

    Biol Psychiatry. 2000 Jun 1;47(11):1000-4.PMID: 10838068 [PubMed - indexed for MEDLINE]Related articles

    39.

    Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.

    Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA.

    J Pharmacol Exp Ther. 2000 Apr;293(1):8-14.PMID: 10734147 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice.

    Miyamoto S, Leipzig JN, Lieberman JA, Duncan GE.

    Neuropsychopharmacology. 2000 Apr;22(4):400-12.PMID: 10700659 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.

    Yui K, Goto K, Ikemoto S, Ishiguro T, Angrist B, Duncan GE, Sheitman BB, Lieberman JA, Bracha SH, Ali SF.

    Mol Psychiatry. 1999 Nov;4(6):512-23. Review.PMID: 10578232 [PubMed - indexed for MEDLINE]Related articles

    43.

    Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia.

    Duncan GE, Zorn S, Lieberman JA.

    Mol Psychiatry. 1999 Sep;4(5):418-28. Review.PMID: 10523814 [PubMed - indexed for MEDLINE]Related articles

    44.

    An integrated view of pathophysiological models of schizophrenia.

    Duncan GE, Sheitman BB, Lieberman JA.

    Brain Res Brain Res Rev. 1999 Apr;29(2-3):250-64. Review.PMID: 10209235 [PubMed - indexed for MEDLINE]Related articles

    45.

    Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

    Duncan GE, Leipzig JN, Mailman RB, Lieberman JA.

    Brain Res. 1998 Nov 23;812(1-2):65-75.PMID: 9813244 [PubMed - indexed for MEDLINE]Related articles

    46.

    Sensitivity to ethanol across development in rats: comparison to [3H]zolpidem binding.

    Moy SS, Duncan GE, Knapp DJ, Breese GR.

    Alcohol Clin Exp Res. 1998 Oct;22(7):1485-92.PMID: 9802533 [PubMed - indexed for MEDLINE]Related articles

    47.

    Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain.

    Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY.

    Pharmacol Biochem Behav. 1998 Jun;60(2):439-48.PMID: 9632227 [PubMed - indexed for MEDLINE]Related articles

    48.

    Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

    Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR.

    Brain Res. 1998 Mar 23;787(2):181-90.PMID: 9518601 [PubMed - indexed for MEDLINE]Related articles

    49.

    Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety.

    Knapp DJ, Duncan GE, Crews FT, Breese GR.

    Alcohol Clin Exp Res. 1998 Apr;22(2):481-93.PMID: 9581657 [PubMed - indexed for MEDLINE]Related articles

    50.

    Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.

    Duncan GE, Knapp DJ, Carson SW, Breese GR.

    J Pharmacol Exp Ther. 1998 May;285(2):579-87.PMID: 9580601 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...